In a symposium beginning Friday at 3:45 p.m. PT in Room 28 of the convention center, experts including Stephen E. Gitelman, MD, will present insights from studies of teplizumab and other agents, including abatacept and hydroxychloroquine, that have provided road maps to help delay the onset of type 1 diabetes. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Starting soon: The Quest to Delay or Prevent Type 1 Diabetes Onset—Recent Interventional Trials
